Pharma & Biotech

The strategic direction for Neutra has undergone a significant change, with its core emphasis now placed squarely on the clinical...

Having secured U.S. approval for its gene therapy Vyjuvek, Krystal Biotech is now executing a deliberate strategy to capture international...

The global diagnostics industry is undergoing a significant strategic realignment. At the heart of this shift is a focus on...

Pharmaceutical giant Pfizer is actively working to secure its future revenue streams as the patent expiration for its blockbuster drug...

Evotec SE has announced a sweeping operational overhaul, sending its stock price lower as the market digested a sharply reduced...

The biopharmaceutical company aTyr Pharma is entering a pivotal period for its lead therapeutic candidate, efzofitimod. Two major clinical and...

As spring approaches, Axsome Therapeutics finds itself at a critical juncture. The biopharmaceutical firm is strengthening its commercial footing with...

The German biotech firm BioNTech is navigating its most significant transition since the peak of the pandemic. Co-founders Ugur Sahin...

In a strategic move to bolster its core pharmaceutical business, Novartis has received expanded U.S. regulatory approval for its immunology...

Canadian biotech firm Onco-Innovations has bolstered its financial position through a private placement, raising capital earmarked for its transition into...